6 Predictions For Healthcare And Biotech In 2024

In 2024, the healthcare and biotech industry is rebounding from pandemic lows with a focus on efficiency and profitability. Companies prioritize conservative strategies over innovation, with acquisitions expected to return but with a focus on value. Startups face pressure to achieve profitability faster, leading to a shift away from fundraising-based models. Telehealth usage stabilizes as patients still prefer in-person visits for most needs, while AI continues to transform healthcare through diagnostic support. Brain health diagnostics and treatments gain traction, reflecting increased demand. Despite challenges, the industry shows promise, prompting a reinvestment surge from cautious investors and a focus on agile operations and marketing strategies for companies.